The Government of Ontario has announced an investment of $18M into medical isotope production at McMaster University’s nuclear reactor. The investment is part of a provincial initiative to double medical isotope production in the next four years. As a result of the investment, the production facility will begin operating on a 24/7 operation schedule, increasing McMaster’s research capacity by 300%. McMaster President Susan Tighe said that “this increased capacity will enhance our ability to serve cancer patients worldwide through the increased production of critical medical isotopes.” The new funding will allow the facility to provide medical isotopes for up to 84,000 treatments per year.
ON
| CHCH
